Ganglioside GM3 Levels Are Altered in a Mouse Model of HIBM: GM3 as a Cellular Marker of the Disease
Thomas Paccalet, Zoé Coulombe, Jacques P. Tremblay · 2010
Read Ganglioside GM3 Levels Are Altered in a Mouse Model of HIBM: GM3 as a Cellular Marker of the Disease by Thomas Paccalet, Zoé Coulombe, Jacques P. Tremblay (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010055.txt.
Description
Thomas Paccalet, Zoe Coulombe, and Jacques Tremblay report a 2010 PLOS ONE mouse study on a rare inherited muscle disease, HIBM. It causes slow adult-onset weakness while sparing the thigh muscle at first. A faulty GNE gene, needed to make a cell sugar acid, causes it.
The team tested whether a muscle fat called GM3 also goes wrong. In mice with the human gene fault, muscle GM3 levels dropped sharply, and so did the message for its making enzyme. Kidney levels stayed normal, so the change is tissue specific. For the first time, a GNE fault is tied to a clear cell change, marking GM3 as a disease sign.
Catalog record
| CREATOR | Thomas Paccalet, Zoé Coulombe, Jacques P. Tremblay |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010055